Skip to main content

Table 1 Discrete Baseline Characteristics

From: Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning

  Patient Percentage (%)
Demographic
 Male 50.4
 Type 1 Diabetes Mellitus 7.37
Comorbidities
 Hypertension 35.6
 Ophthalmological Complications 32.2
 Ischemic Heart Disease 16.2
 Ischemic Stroke and Transient Ischemic Attack 11.8
 Heart Failure 9.8
 Chronic Renal Disease 8.8
 Chronic Liver Disease 5.8
 Acute Myocardial Infarction 5.1
 Chronic Obstructive Pulmonary Disease 3.5
Anti-diabetic Medication
 Biguanide 57.6
 Sulphonylurea 41.5
 Thiazolidinedione 3.5
 Alpha-Glucosidase 3.0
 Dipeptidyl Peptidase-4 Inhibitor 0.4
 Glucagon-Like Peptide-1 Receptor Agonist < 0.1
Cardiovascular medication
 Angiotensinogen-Converting Enzyme Inhibitor/ Angiotensin-Receptor Blocker 59.8
 Calcium Channel Blocker 43.6
 Lipid-Lowering Agents 42.4
 Aspirin 36.2
 Diuretic 29.2
 Beta-Adrenergic Receptor Blocker 28.1